AN2 Therapeutics , Inc. (NASDAQ:ANTX), a biopharmaceutical company focused on developing treatments for infectious diseases, ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

Dogecoin price rally fuels market excitement as this potential rival gains traction, targeting a surge from $0.10 to $1 ...

Serina Therapeutics (SER) announced the closing of the second $5M tranche of its previously announced $10M equity financing with strategic ...

Single dose relabotulinumtoxinA demonstrated rapid onset, long-lasting duration of aesthetic efficacy and high patient ...

The expectations have been set for the Giants to become more competitive next season, and here’s a few ways they can do so beyond personnel changes.

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

Starting Tuesday, nearly all imports from Canada and Mexico will be charged a 25% tariff, while goods from China will be ...

Horses trained by Bob Baffert hold the top spots on both the Kentucky Derby and Kentucky Oaks leaderboards after weekend wins ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...

Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...